Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa; and has a preclinical program comprising IV/oral rigosertib for COVID-19. It has a license agreement with SymBio Pharmaceuticals Limited; license, development, and commercialization agreement with Pint International SA.; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc. for the development, registration, and commercialization of narazaciclib. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Onconova Therapeutics Inc..
Onconova Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Onconova Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Onconova Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Onconova Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Onconova Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Onconova Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Onconova Therapeutics Inc.- Key Facts
2.2 Onconova Therapeutics Inc.- Geographic Locations
2.3 Onconova Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Onconova Therapeutics Inc.- Business Divisions
2.5 Onconova Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Onconova Therapeutics Inc. Strategic Analysis Review
3.1 Onconova Therapeutics Inc.- Key Strategies
3.2 Onconova Therapeutics Inc.- Company Outlook Statement
3.3 Onconova Therapeutics Inc.- SWOT Analysis
3.3.1 Onconova Therapeutics Inc.- Key Strengths
3.3.2 Onconova Therapeutics Inc.- Key Weaknesses
3.3.3 Onconova Therapeutics Inc.- Potential Opportunities
3.3.4 Onconova Therapeutics Inc.- Potential Threats
3.4 Onconova Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Onconova Therapeutics Inc.- Business Overview
4.2 Onconova Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Onconova Therapeutics Inc.- Key Products
5.2 Onconova Therapeutics Inc.- Key Service Areas
5.3 Onconova Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Onconova Therapeutics Inc.- Company History
6.2 Onconova Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Onconova Therapeutics Inc.- Income Statements
7.2 Onconova Therapeutics Inc.- Balance Sheet
7.3 Onconova Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Onconova Therapeutics Inc.- Direct Competitors
8.2 Onconova Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Onconova Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Onconova Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
